Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASND Ascendis Pharma A/S

休市中 12-20 15:59:59 EST

136.38

-1.36

-0.99%

盘后136.38

+0.000.00%

17:21 EST

最高141.37	最低135.61	成交量69.03万
今开137.00	昨收137.74	日振幅4.18%
总市值81.50亿	流通市值80.90亿	总股本5,976万
成交额9,488万	换手率1.16%	流通股本5,932万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":136.38,"timestamp":1734728399999,"preClose":137.74,"halted":0,"volume":690269,"hourTrading":{"tag":"盘后","latestPrice":136.38,"preClose":136.38,"latestTime":"17:21 EST","volume":63078,"amount":8602577.64,"timestamp":1734733301324},"delay":0,"floatShares":59319788,"shares":59760414,"eps":-8.333144,"marketStatus":"休市中","marketStatusCode":7,"change":-1.36,"latestTime":"12-20 15:59:59 EST","open":137,"high":141.37,"low":135.61,"amount":94877874.40602,"amplitude":0.041818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.333144,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":1,"listingDate":1422421200000,"adjPreClose":137.74,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":136.5,"preClose":137.74,"latestTime":"08:24 EST","volume":127,"amount":17341.3293,"timestamp":1734701044769},"postHourTrading":{"tag":"盘后","latestPrice":136.38,"preClose":136.38,"latestTime":"17:21 EST","volume":63078,"amount":8602577.64,"timestamp":1734733301324},"volumeRatio":1.3778830953479215,"impliedVol":0.4195,"impliedVolPercentile":0.2143},"requestUrl":"/m/hq/s/ASND","defaultTab":"news","newsList":[{"id":"2492614215","title":"Ascendis Pharma A/S盘中异动 大幅拉升5.07%报136.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492614215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492614215?lang=zh_cn&edition=full","pubTime":"2024-12-17 00:49","pubTimestamp":1734367771,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日00时49分，Ascendis Pharma A/S股票出现异动，股价快速拉升5.07%。截至发稿，该股报136.45美元/股，成交量10.2461万股，换手率0.17%，振幅5.05%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.73%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217004931984c7397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217004931984c7397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","ASND","BK4139","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"1120371630","title":"异动解读 | 阿森迪斯制药创下亮眼财报业绩,获机构力挺盘中股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120371630","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120371630?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:28","pubTimestamp":1732296501,"startTime":"0","endTime":"0","summary":"阿森迪斯制药昨日盘中大涨5.19%,引发市场广泛关注。作为一家生物科技公司,阿森迪斯制药凭借其独有的Transcon技术开发多款新药,产品线丰富,满足患者医疗需求。随着各款新药产品线的不断推出,公司将持续受益于收入与净利润的增长。本次财报与机构评级的利好作用下,投资者对该股长期增长动力更加乐观,因而推动股价大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 阿森迪斯制药创下亮眼财报业绩,获机构力挺盘中股价大涨5.19%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"gpt_icon":0},{"id":"2485629134","title":"Ascendis Pharma A/S盘中异动 快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485629134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485629134?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:23","pubTimestamp":1732296198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时23分，Ascendis Pharma A/S股票出现异动，股价大幅上涨5.12%。截至发稿，该股报128.92美元/股，成交量11.0917万股，换手率0.19%，振幅4.25%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1837.91%、148.85%、93.32%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为72.68%、71.43%、63.64%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123012318abd7d747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123012318abd7d747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","ASND","LU0889565916.HKD","BK4139","LU0320765992.SGD","BK4585"],"gpt_icon":0},{"id":"2485298917","title":"Ascendis Pharma A/S2024财年第三财季实现净利润-1.09亿美元，同比增加38.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298917?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291391,"startTime":"0","endTime":"0","summary":"11月23日，Ascendis Pharma A/S公布财报，公告显示公司2024财年第三财季净利润为-1.09亿美元，同比增加38.07%；其中营业收入为63.53百万美元，同比增加21.59%，每股基本收益为-1.89美元。机构评级：截至2024年11月23日，当前有14家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为194.76美元，其中最低目标价为152.87美元，最高目标价为288.75美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000336abd7b95c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000336abd7b95c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2483630089","title":"美国研究综述-应用材料公司、迪士尼、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630089","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630089?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:28","pubTimestamp":1731691712,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、迪士尼、沃尔玛路透11月15日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括应用材料公司、迪士尼和沃尔玛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADSK","BTM","BV","AGYS","ASND","LNG","CABA","BIIB","BMY","IE00BBT3K403.USD","AKYA","LU0354030511.USD","ASTS","LU1861217088.USD","BL","AFG","AESI","AHCO","LU1074936037.SGD","AHR","AROC","AAP","ASB","LU0868494708.USD","APH","AMAT","ALGT","BRX","BAC","BKR","BRZE","IE00BKVL7J92.USD","LU1032466523.USD","CAVA","ARI","AAL","LU1267930227.SGD","CHX","ALK","BK4534","BLUE","CELC","BJ","BK4588","AIN","ARE","SCHW","AGCO","AMH","BE"],"gpt_icon":1},{"id":"2483372400","title":"Ascendis Pharma A/S盘中异动 急速下挫5.00%报118.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372400?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:30","pubTimestamp":1731681038,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时30分，Ascendis Pharma A/S股票出现异动，股价急速下挫5.00%。截至发稿，该股报118.07美元/股，成交量1.0082万股，换手率0.02%，振幅0.00%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.00%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223038a23b5b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223038a23b5b84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASND","LU0889565916.HKD","LU0109394709.USD","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2474402037","title":"Ascendis Pharma A/S盘中异动 快速跳水5.13%报132.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474402037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474402037?lang=zh_cn&edition=full","pubTime":"2024-10-09 02:59","pubTimestamp":1728413990,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日02时59分，Ascendis Pharma A/S股票出现异动，股价急速跳水5.13%。截至发稿，该股报132.00美元/股，成交量62.1275万股，换手率1.04%，振幅8.07%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.49%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009025951a1df1750&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009025951a1df1750&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ASND","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2470777102","title":"长效生长激素龙头“维升药业-B”四度递表，核心产品已报产","url":"https://stock-news.laohu8.com/highlight/detail?id=2470777102","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470777102?lang=zh_cn&edition=full","pubTime":"2024-09-27 17:43","pubTimestamp":1727430180,"startTime":"0","endTime":"0","summary":"来源：活报告摘要：维升药业-B于2024年9月26日向港交所递交招股书，拟在香港主板上市，公司曾在2022年11月17日、2023年8月16日、2024年3月21日递表，这是该公司第4次递交上市申请，联席保荐人为大摩及Jefferies。隆培促生长素是首个在美国及欧洲获批上市的长效生长激素，用于治疗儿童生长激素缺乏症。截至2024年4月30日，公司账上现金3亿元，经营活动现金流为负0.47亿，流动负债总额0.41亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-09-27/doc-incqqumy1673342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0057","BK0075","BK0188","ASND","LU0889565916.HKD","LU0320765992.SGD","BK0239","BK4585","BK0028","BK4139","000661","LU0109394709.USD"],"gpt_icon":0},{"id":"2465551080","title":"Ascendis Pharma A/S2024财年第二财季实现净利润-1.18亿美元，同比增加10.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2465551080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465551080?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:00","pubTimestamp":1725494413,"startTime":"0","endTime":"0","summary":"9月5日，Ascendis Pharma A/S公布财报，公告显示公司2024财年第二财季净利润为-1.18亿美元，同比增加10.61%；其中营业收入为38.75百万美元，同比减少24.87%，每股基本收益为-2.05美元。机构评级：截至2024年9月5日，当前有13家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为184.26美元，其中最低目标价为157.11美元，最高目标价为264.18美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409050800209ee0f0be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409050800209ee0f0be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"1144775491","title":"异动解读 | Ascendis Pharma A/S盘前大跌17.58%,分析师下调股价目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1144775491","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144775491?lang=zh_cn&edition=full","pubTime":"2024-09-04 19:34","pubTimestamp":1725449659,"startTime":"0","endTime":"0","summary":"Ascendis Pharma A/S(ASND)今日盘前股价大跌17.58%,引发市场关注。\n\n从新闻报导来看,此番大跌或与分析师下调对该公司的评级和目标价有关。根据FactSet最新调查显示,目前共有13位分析师对ASND股票提供评级,其中12人给予积极评价,1人中立。不过,分析师们普遍将该股的目标价从180.02美元下修至164.29美元,下调幅度达8.74%。\n\n此外,另有分析师下调了对ASND明年每股收益的预期,中位数预估从-5.81美元下修至-6.01美元。分析师对该公司未来几年的营收预期也有所下调。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND"],"gpt_icon":0},{"id":"2464329959","title":"美国研究综述-Array Technologies、Hess、Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2464329959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464329959?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:43","pubTimestamp":1725443007,"startTime":"0","endTime":"0","summary":"    路透9月4日 - 华尔街证券分析师周三调整了对 Array Technologies、Hess 和 Lennar 等几家美国上市公司的评级和目标价。要闻    * Array Technologies Inc   ：杰富瑞维持 \"买入 \"评级，目标价11美元。* Nextracker Inc   ：杰富瑞给予 \"持有 \"评级，目标价46美元             * Nuvalent Inc   ：摩根大通将目标价从90美元上调至100美元             * 西方石油公司  ：Susquehanna 将目标价从 81 美元下调至 78 美元             * Onestream Inc   ：Piper Sandler将目标价从32美元上调至34美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","LU0823414478.USD","NUVL","LEN","LRMR","FAF","FSLR","LU","BK4519","GEV","ATHA","LU0053666078.USD","GWRE","FANG","HASI","ABNB","FLNC","AMRC","MITK","NXT","ASND","AFCG","FRPT","MGY","LU1093756168.USD","COP","MRO","ENPH","LU1988902786.USD","LU1992135472.HKD","ARRY","GTLB","CTRA","CASY","ASAN","BBIO","LU0130102774.USD","BKNG","ORKA","FNF","DVN","LU0348723411.USD","LU0154245673.USD","CDP","HES","APA","EOG","STZ","LU0082616367.USD"],"gpt_icon":1},{"id":"2464299513","title":"美国研究综述-Array Technologies、Hess、Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2464299513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464299513?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:43","pubTimestamp":1725443007,"startTime":"0","endTime":"0","summary":"    路透9月4日 - 华尔街证券分析师周三调整了对 Array Technologies、Hess 和 Lennar 等几家美国上市公司的评级和目标价。要闻    * Array Technologies Inc   ：杰富瑞维持 \"买入 \"评级，目标价11美元。* Nextracker Inc   ：杰富瑞给予 \"持有 \"评级，目标价46美元             * Nuvalent Inc   ：摩根大通将目标价从90美元上调至100美元             * 西方石油公司  ：Susquehanna 将目标价从 81 美元下调至 78 美元             * Onestream Inc   ：Piper Sandler将目标价从32美元上调至34美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","GTLB","FNF","ASAN","BK4519","LU1992135472.HKD","AMRC","LU0082616367.USD","ASND","LRMR","GEV","NXT","EOG","HES","LU0154245673.USD","OS","FANG","FAF","MRO","CASY","COP","AFCG","LU0053666078.USD","STZ","ABNB","OXY","FLNC","LU","ORKA","CTRA","MGY","NUVL","MITK","BBIO","LU0823414478.USD","ATHA","BKNG","ENPH","CDP","LEN","HASI","ARRY","GWRE","LU1988902786.USD","APA","FRPT","FSLR","LU1093756168.USD","LU0348723411.USD","DVN"],"gpt_icon":0},{"id":"2461009825","title":"美国研究综述-Agree Realty、Global Payments、Snowflake","url":"https://stock-news.laohu8.com/highlight/detail?id=2461009825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461009825?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:23","pubTimestamp":1724246592,"startTime":"0","endTime":"0","summary":"    路透8月21日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Agree Realty、Global Payments 和 Snowflake。要闻  * Agree Realty Corp   ：雷蒙德-詹姆斯将目标价从70美元上调至81美元 * Coinbase Global Inc   ：杰富瑞将目标价从245美元下调至220美元 * Global Payments Inc   ：杰富瑞将目标价从 120 美元上调至 130 美元 * Quest Diagnostics Inc   ：摩根大通将目标价从155美元上调至173美元 * Snowflake Inc   ：贝尔德将目标价从200美元下调至165美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNMR","BV","COTY","DBRG","EPR","ACIW","LU1861559042.SGD","COR","AADI","COIN","AXP","CCOI","GLW","CIFR","DEI","EOSE","AEO","IE0004445015.USD","BK4196","CPB","LU0211328371.USD","ADC","BOC","CAH","EPRT","FIVN","LU0310800965.SGD","GNL","CDNA","ATI","CIVI","CX","LU1861558580.USD","BK4585","PINE","BMRN","LU0011850046.USD","BK4205","DOCS","CHWY","CI","CHRD","GLPI","LU2552382215.SGD","SNOW","EQIX","FCPT","ASND","ADSK"],"gpt_icon":1},{"id":"2459190029","title":"Ascendis Pharma A/S盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459190029","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459190029?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:48","pubTimestamp":1723560486,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时48分，Ascendis Pharma A/S股票出现波动，股价急速拉升5.00%。截至发稿，该股报134.90美元/股，成交量10.5394万股，换手率0.18%，振幅4.51%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.73%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224807a1d43418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224807a1d43418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0320765992.SGD","ASND","LU0889565916.HKD","BK4585"],"gpt_icon":0},{"id":"2458856859","title":"Ascendis Pharma A/S盘中异动 快速上涨7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458856859","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458856859?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:32","pubTimestamp":1723469543,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时32分，Ascendis Pharma A/S股票出现波动，股价急速上涨7.95%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为39.84%、19.87%、8.54%，振幅较大的相关个股有Oragenics Inc.、Sangamo Therapeutics, Inc.、Abcellera Biologics Inc.，振幅分别为23.21%、22.55%、12.69%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122132239592951b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122132239592951b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0109394709.USD","LU0320765992.SGD","BK4139","ASND","LU0889565916.HKD"],"gpt_icon":0},{"id":"2456238657","title":"Ascendis Pharma A/S盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456238657","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456238657?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:24","pubTimestamp":1722608684,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时24分，Ascendis Pharma A/S股票出现波动，股价急速跳水5.27%。截至发稿，该股报129.33美元/股，成交量5.0792万股，换手率0.09%，振幅4.17%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为2.48%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802222444968234cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802222444968234cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","LU0889565916.HKD","LU0320765992.SGD","ASND","LU0109394709.USD"],"gpt_icon":0},{"id":"2446784604","title":"Ascendis Pharma A/S盘中异动 早盘快速上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446784604","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446784604?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:30","pubTimestamp":1719322248,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时30分，Ascendis Pharma A/S股票出现异动，股价快速拉升6.58%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为84.60%、75.49%、56.15%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Allarity Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为12.48%、6.65%、6.04%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213048aef686cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213048aef686cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","BK4585","ASND","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":0.0501},{"period":"1month","weight":0.0965},{"period":"3month","weight":-0.0984},{"period":"6month","weight":0.0667},{"period":"1year","weight":0.1197},{"period":"ytd","weight":0.0828}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司，该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品，TransCon人生长激素或生长激素TransCon，每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037189},{"month":2,"riseRate":0.5,"avgChangeRate":0.037735},{"month":3,"riseRate":0.5,"avgChangeRate":0.039038},{"month":4,"riseRate":0.3,"avgChangeRate":-0.046884},{"month":5,"riseRate":0.4,"avgChangeRate":0.000611},{"month":6,"riseRate":0.6,"avgChangeRate":0.017012},{"month":7,"riseRate":0.6,"avgChangeRate":-0.000153},{"month":8,"riseRate":0.7,"avgChangeRate":0.081464},{"month":9,"riseRate":0.6,"avgChangeRate":0.041437},{"month":10,"riseRate":0.4,"avgChangeRate":-0.012194},{"month":11,"riseRate":0.8,"avgChangeRate":0.046776},{"month":12,"riseRate":0.5,"avgChangeRate":0.044803}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}